Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- Angle reports wider loss, awaits FDA decision on cancer test equipment
29 Apr 2021 - IN BRIEF: Angle enrolls 200 patients for ovarian cancer test study
26 Apr 2021 - Angle completes patient enrolment for ovarian cancer study
26 Apr 2021 - UK earnings, trading statements calendar - next 7 days
22 Apr 2021 - Angle secures first large-scale pharma services contract
16 Apr 2021 - TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract
16 Apr 2021 - IN BRIEF: Angle launches clinical services laboratories in UK and US
30 Mar 2021 - Angle completes clinical labs in Guildford and Pennsylvania
30 Mar 2021
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
Angle reports wider loss, awaits FDA decision on cancer test equipment
Angle reports wider loss, awaits FDA decision on cancer test equipment
IN BRIEF: Angle enrolls 200 patients for ovarian cancer test study
IN BRIEF: Angle enrolls 200 patients for ovarian cancer test study
Angle completes patient enrolment for ovarian cancer study
(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 200-patient ovarian cancer clinical verification study had completed patie...
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Angle secures first large-scale pharma services contract
(Sharecast News) - Liquid biopsy company Angle has secured its first large-scale pharma services contract, it announced on Friday.
TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract
TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract
IN BRIEF: Angle launches clinical services laboratories in UK and US
IN BRIEF: Angle launches clinical services laboratories in UK and US
Angle completes clinical labs in Guildford and Pennsylvania
(Sharecast News) - Liquid biopsy company Angle has completed the fitout and staffing of its clinical services laboratories in Guildford and Pennsylvan...
Follow the stocks
